How much funding has Coherus Biosciences raised?

Coherus Biosciences has raised $119.7M in total funding, most recently a Corporate Round.

Who are Coherus Biosciences's investors?

Coherus Biosciences's investors include Venrock, Junshi Biosciences, Pharmakon Advisors, KKR, Janus Henderson Investors, HBM Healthcare Investments.

When was Coherus Biosciences founded?

Coherus Biosciences was founded in 2010.

Where is Coherus Biosciences headquartered?

Coherus Biosciences is headquartered in Redwood City, California, United States.

What industry is Coherus Biosciences in?

Coherus Biosciences operates in Biotech, Healthcare, Life Sciences.

How many employees does Coherus Biosciences have?

Coherus Biosciences has 201-500 employees.

Coherus Biosciences

IPO

Overcoming immune resistance in cancer

Public · Redwood City, United States · Founded 2010 · $119.7M raised

Biotech

Healthcare

Life Sciences

Headquarters: Redwood City, California
Employees: 201–500
Founded: 2010
Business Model: B2B
Website: coherus.com

Total Funding: $119.7M
Last Round: $50.0M Corporate RoundJan 2023
Rounds: 3
Type: Public

About

Coherus Oncology (formerly Coherus Biosciences) is a fully integrated commercial-stage biopharmaceutical company focused on developing and commercializing next-generation immuno-oncology therapies. Its approved product LOQTORZI (toripalimab-tpzi) is a PD-1 inhibitor for hard-to-treat cancers. The company's pipeline includes multiple clinical-stage candidates targeting the tumor microenvironment, including CCR8 and IL-27 pathways, with the goal of extending patient survival across tumor types.

Summary

Coherus Biosciences is a Biotech company based in Redwood City, United States, founded in 2010. It has raised $119.7M in total across 3 rounds, most recently a $50.0M Corporate Round round in Jan 2023. Investors include Venrock, Junshi Biosciences and Pharmakon Advisors.

LinkedIn X (Twitter)